DOI:
10.1055/s-00000104
Zentralblatt für Chirurgie
LinksClose Window
References
Fisher CJ, Slotman GJ, Opal SM. et al.
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. The IL-1RA Sepsis Syndrome Study Group.
Crit Care Med 1994; 22: 12-21
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.